Back
Nuvalent, Inc. 10K Form
Sell
45
NUVL
Nuvalent, Inc.
Last Price:
$108.36
Seasonality Move:
-9.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NUVL News And Ratings
See the #1 stock for the next 7 days that we like better than NUVL
NUVL Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-70.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.70 |
| Price / Book: | 9.19 |
Profitability
| EPS (TTM): | -5.31610 |
|---|---|
| Net Income (TTM): | $-381.4M |
| Gross Margin: | $0 |
| Return on Equity: | -38.24% |
| Return on Assets: | -34.95% |
Nuvalent, Inc. Earnings Forecast
Key Nuvalent, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 0 years.
Nuvalent, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NUVL |
| Website: | nuvalent.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 10.73 |
| Quick Ratio: | 10.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NUVL Technical Analysis vs Fundamental Analysis
Sell
45
Nuvalent, Inc. (NUVL)
is a Sell
Is Nuvalent, Inc. a Buy or a Sell?
-
Nuvalent, Inc. stock is rated a SellThe current Nuvalent, Inc. [NUVL] share price is $106.86. The Score for NUVL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.